M Moehler Selected Research

M Moehler Research Topics

12	Neoplasms (Cancer) 01/2020 - 07/2008
7	Stomach Neoplasms (Stomach Cancer) 02/2022 - 06/2005
7	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 12/2002
4	Adenocarcinoma 01/2022 - 01/2007
3	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 03/2001
3	Disease Progression 07/2011 - 12/2002
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 12/2014 - 12/2009
2	Lymphatic Metastasis 12/2014 - 09/2009
1	Turcot syndrome 02/2022
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2020
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2020
1	Vaccinia 01/2019
1	Virus Diseases (Viral Diseases) 01/2017
1	Melanoma (Melanoma, Malignant) 01/2017
1	Colonic Neoplasms (Colon Cancer) 02/2016
1	Inflammation (Inflammations) 02/2016
1	Neoplasm Metastasis (Metastasis) 12/2014
1	Ascites 08/2012
1	Pancreatic Neoplasms (Pancreatic Cancer) 03/2012
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 07/2011
1	Necrosis 02/2010
1	Gallbladder Neoplasms (Gallbladder Cancer) 12/2009
1	Carcinoma (Carcinomatosis) 12/2009
1	Bile Duct Neoplasms (Bile Duct Cancer) 12/2009
1	Thrombocytopenia (Thrombopenia) 12/2009
1	Anorexia 12/2009
1	Neutropenia 12/2009
1	Diarrhea 10/2009
1	Exanthema (Rash) 10/2009
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2009
1	Esophageal Squamous Cell Carcinoma 10/2009
1	Carcinogenesis 07/2009
1	Liver Diseases (Liver Disease) 07/2008
1	Esophagitis 01/2004
1	Infections 03/2001

10	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 12/2002
6	Irinotecan (Camptosar)FDA LinkGeneric 01/2020 - 12/2002
5	Cetuximab (Erbitux)FDA Link 01/2020 - 10/2009
4	ErbB Receptors (EGF Receptor)IBA 01/2022 - 06/2011
4	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 10/2009
4	Leucovorin (Folinic Acid)FDA Link 01/2020 - 12/2002
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2010 - 12/2002
3	Trastuzumab (Herceptin)FDA Link 01/2022 - 07/2011
3	Bevacizumab (Avastin)FDA Link 01/2020 - 01/2019
3	Gemcitabine FDA Link 12/2014 - 01/2007
3	Biomarkers (Surrogate Marker)IBA 12/2014 - 06/2011
2	Sorafenib (BAY 43-9006)FDA Link 01/2019 - 12/2014
2	Capecitabine (Xeloda)FDA Link 03/2012 - 01/2010
1	PlatinumIBA 01/2022
1	Panitumumab (Vectibix)FDA Link 01/2020
1	AntigensIBA 01/2019
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2019
1	Carcinoembryonic AntigenIBA 01/2019
1	CalreticulinIBA 01/2017
1	HMGB1 Protein (HMG1)IBA 01/2017
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	Lugol's solution (Lugol's iodine)IBA 02/2016
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 12/2014
1	catumaxomabIBA 08/2012
1	Epithelial Cell Adhesion MoleculeIBA 08/2012
1	Sunitinib (Sutent)FDA Link 07/2011
1	Growth Factor ReceptorsIBA 08/2010
1	LigandsIBA 02/2010
1	mapatumumabIBA 02/2010
1	Monoclonal AntibodiesIBA 02/2010
1	BilirubinIBA 12/2009
1	Codon (Codons)IBA 10/2009
1	Chemokine ReceptorsIBA 07/2006
1	Etoposide (VP 16)FDA LinkGeneric 06/2005
1	LuciferasesIBA 03/2001

8	Drug Therapy (Chemotherapy) 02/2022 - 12/2002
6	Therapeutics 01/2022 - 07/2009
3	Immunotherapy 01/2019 - 08/2006
1	Oncolytic Virotherapy 01/2017
1	Punctures 08/2012
1	Aftercare (After-Treatment) 08/2012
1	Combination Drug Therapy (Combination Chemotherapy) 07/2011
1	Palliative Care (Palliative Therapy) 07/2008
1	Endoscopes 01/2004
1	Salvage Therapy 12/2002